Skip to main content
. 2019 Feb 20;14(2):e0211759. doi: 10.1371/journal.pone.0211759

Fig 1. Trends in access to antidiabetic, antihypertensive and antilipidemic drugs in the NLEM per 1,000 population*, Q1, FY 2010—Q4, FY 2012.

Fig 1

*Age 15 years or older. NLEM, National List of Essential Medicines; Q, quarter; FY, fiscal year. Antidiabetics: insulin, metformin, glibenclamide, glipizide, and pioglitazone; Antihypertensive agents: amlodipine, nifedipine, enalapril, and losartan; Antilipidemics: simvastatin, atorvastatin, gemfibrozil, and fenofibrate.